American Century Companies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,705
| Closed | -$394K | – | 2990 |
|
|
2023
Q4 | $394K | Sell |
6,705
-23,633
| -78% | -$1.33M | ﹤0.01% | 2460 |
|
|
2023
Q3 | $1.32M | Buy |
30,338
+15,255
| +101% | +$545K | ﹤0.01% | 1884 |
|
|
2023
Q2 | $545K | Buy |
15,083
+8,884
| +143% | +$366K | ﹤0.01% | 2179 |
|
|
2023
Q1 | $227K | Buy |
6,199
+286
| +5% | +$12.9K | ﹤0.01% | 2382 |
|
|
2022
Q4 | $268K | Buy |
5,913
+2,538
| +75% | +$164K | ﹤0.01% | 2255 |
|
|
2022
Q3 | $236K | Buy |
+3,375
| New | +$250K | ﹤0.01% | 2187 |
|
|
2022
Q1 | – | Sell |
-1,774
| Closed | -$260K | – | 2373 |
|
|
2021
Q4 | $260K | Buy |
1,774
+363
| +26% | +$56.4K | ﹤0.01% | 2132 |
|
|
2021
Q3 | $250K | Buy |
1,411
+163
| +13% | +$26.2K | ﹤0.01% | 2137 |
|
|
2021
Q2 | $202K | Sell |
1,248
-60,537
| -98% | -$9.72M | ﹤0.01% | 2191 |
|
|
2021
Q1 | $10.6M | Sell |
61,785
-616
| -1% | -$122K | 0.01% | 769 |
|
|
2020
Q4 | $13.7M | Sell |
62,401
-2,374
| -4% | -$513K | 0.01% | 700 |
|
|
2020
Q3 | $10.8M | Buy |
64,775
+3,355
| +5% | +$459K | 0.01% | 696 |
|
|
2020
Q2 | $7.01M | Buy |
+61,420
| New | +$5.96M | 0.01% | 737 |
|
|
2020
Q1 | – | Sell |
-43,197
| Closed | -$5.57M | – | 1748 |
|
|
2019
Q4 | $5.57M | Buy |
43,197
+18,390
| +74% | +$1.77M | 0.01% | 792 |
|
|
2019
Q3 | $1.93M | Buy |
24,807
+1,434
| +6% | +$135K | ﹤0.01% | 973 |
|
|
2019
Q2 | $2.41M | Sell |
23,373
-73
| -0.3% | -$5.68K | ﹤0.01% | 999 |
|
|
2019
Q1 | $1.72M | Buy |
+23,446
| New | +$1.59M | ﹤0.01% | 1007 |
|
Other funds holding MRTX
American Century Companies's MRTX Position: Q1 2024 in Review
American Century Companies sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 6,705 shares — an estimated $394K sold.
American Century Companies first reported a position in MRTX in Q1 2019 and held it in 17 quarters. The position peaked at $13.7M in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- American Century Companies reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- American Century Companies sold 6,705 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $394K.
- American Century Companies first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2019 and held it in 17 quarters.
- American Century Companies's Mirati Therapeutics, Inc. Common Stock position peaked at $13.7M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.